Bethyl Laboratories
Rabbit anti-HDAC2 IHC Antibody Affinity Purified
Primary
Catalog #IHC-00057
TargetHDAC2
HostRabbit
ClonalityPolyclonal
ReactivityMouse, Human
ApplicationIHC, IHC-IF
Image 1 of 2
local_shipping
Order within 3 hours and 28 minutes for shipment by today
Product Description
Histone deacetylase 2 (HDAC2) is a class I histone deacetylase that catalyzes the removal of the acetyl group on lysine residues of the N-terminus of the core histones H2A, H2B, H3, and H4. HDAC2 is a component of multiple deacetylating complexes such as Sin3, NuRD, and CoRest that function to repress gene transcription.
Specifications
Clonality
Polyclonal
Host
Rabbit
Immunogen
Between 438 and C-terminus
Isotype
IgG
Reactivity
Mouse, Human
Format
Whole IgG
Conjugate Type
Unconjugated
Purity
Antigen Affinity Purified
Concentration
100 µg/ml
Target Identity
TargetHDAC2
Antigen Species
Human
Gene ID3066
Gene Symbol
HDAC2
Gene Name
histone deacetylase 2
Uniprot IDQ92769
Protein Name
Histone deacetylase 2
Alternate Names
Product Information
Applications
IHC, IHC-IF
Buffer
Tris-buffered Saline containing 0.1% BSA and 0.09% Sodium Azide
Storage Conditions
2 - 8 °C
Physical State
Liquid
Shelf Life
1 year from date of receipt
Country of Origin
USA
Production & Epitope
Antibody was affinity purified using an epitope specific to HDAC2 immobilized on solid support.
The epitope recognized by IHC-00057 maps to a region between residue 425 and the C-terminus (residue 488) of human Histone Deacetylase 2 using the numbering given in entry NP_001518.1 (GeneID 3066).
Applications
Epitope exposure is recommended.
Immunohistochemistry (IHC)1:100 - 1:500
Immunohistochemistry-Immunofluoresence (IHC-IF)1:50 - 1:500
Documents
Safety Data SheetPDF · IHC-00057Open
Product DatasheetPDF · IHC-00057 · Lot 1 (current lot)Open
Product DatasheetPDF · IHC-00057 · Lot 1 (current lot)Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1